References
- Aliberti S, Sotgiu G, Lapi F, Gramegna A, Cricelli C, Blasi F. Prevalence and incidence of bronchiectasis in Italy. BMC Pulm Med. 2020;20(1):15. doi:https://doi.org/10.1186/s12890-020-1050-0.
- Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest. 2012;142(2):432–439. doi:https://doi.org/10.1378/chest.11-2209.
- Whitters D, Stockley R. Immunity and bacterial colonisation in bronchiectasis. Thorax. 2012;67(11):1006–1013. doi:https://doi.org/10.1136/thoraxjnl-2011-200206.
- Ringshausen FC, de Roux A, Pletz MW, Hämäläinen N, Welte T, Rademacher J. Bronchiectasis-associated hospitalizations in Germany, 2005–2011: a population-based study of disease burden and trends. PLoS One. 2013;8(8):e71109. doi:https://doi.org/10.1371/journal.pone.0071109.
- Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005; 12:205–209.
- Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993–2006. Chest. 2010;138(4):944–949. doi:https://doi.org/10.1378/chest.10-0099.
- Gursel G. Does coexistence with bronchiectasis influence intensive care unit outcome in patients with chronic obstructive pulmonary disease? Heart Lung. 2006;35(1):58–65. doi:https://doi.org/10.1016/j.hrtlng.2005.04.003.
- Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, Polverino E, Van de Kerkhove C, Rutherford R, Davison J, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764–1770. doi:https://doi.org/10.1513/AnnalsATS.201507-472OC.
- Pang J, Chan HS, Sung JY. Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study. Thorax. 1989;44(11):948–951. doi:https://doi.org/10.1136/thx.44.11.948.
- Oguzulgen IK, Kervan F, Ozis T, Turktas H. The impact of bronchiectasis in clinical presentation of asthma. South Med J. 2007;100(5):468–471. doi:https://doi.org/10.1097/SMJ.0b013e31802fa16f.
- Mao B, Yang JW, Lu HW, Xu JF. Asthma and bronchiectasis exacerbation. Eur Respir J. 2016;47(6):1680–1686. doi:https://doi.org/10.1183/13993003.01862-2015.
- Lynch DA, Newell JD, Tschomper BA, Cink TM, Newman LS, Bethel R. Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology. 1993;188(3):829–833. doi:https://doi.org/10.1148/radiology.188.3.8351357.
- Paganin F, Séneterre E, Chanez P, Daurés JP, Bruel JM, Michel FB, Bousquet J. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med. 1996;153(1):110–114. doi:https://doi.org/10.1164/ajrccm.153.1.8542102.
- Grenier P, Mourey-Gerosa I, Benali K, Brauner MW, Leung AN, Lenoir S, Cordeau MP, Mazoyer B. Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability. Eur Radiol. 1996;6(2):199–206. doi:https://doi.org/10.1007/BF00181147.
- Park JW, Hong YK, Kim CW, Kim DK, Choe KO, Hong CS. High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J Investig Allergol Clin Immunol. 1997;7(3):186–192.
- Cukier A, Stelmach R, Kavakama JI, Terra Filho M, Vargas F. Persistent asthma in adults: comparison of high resolution computed tomography of the lungs after one year of follow-up. Rev Hosp Clin Fac Med Sao Paulo. 2001;56(3):63–68. doi:https://doi.org/10.1590/s0041-87812001000300001.
- Gupta S, Siddiqui S, Haldar P, Raj JV, Entwisle JJ, Wardlaw AJ, Bradding P, Pavord ID, Green RH, Brightling CE, et al. Qualitative analysis of high-resolution CT scans in severe asthma. Chest. 2009;136(6):1521–1528. doi:https://doi.org/10.1378/chest.09-0174.
- Bisaccioni C, Aun MV, Cajuela E, Kalil J, Agondi RC, Giavina-Bianchi P. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. Clinics (Sao Paulo). 2009;64(8):769–773. doi:https://doi.org/10.1590/S1807-59322009000800010.
- Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66(5):679–685. doi:https://doi.org/10.1111/j.1398-9995.2010.02542.x.
- Luján M, Gallardo X, Amengual MJ, Bosque M, Mirapeix RM, Domingo C. Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels. Biomed Res Int. 2013;2013:1–7. doi:https://doi.org/10.1155/2013/109219.
- Weatherburn CJ, Guthrie B, Mercer SW, Morales DR. Comorbidities in adults with asthma: population-based cross-sectional analysis of 1.4 million adults in Scotland. Clin Exp Allergy. 2017;47(10):1246–1252. doi:https://doi.org/10.1111/cea.12971.
- Dimakou K, Gousiou A, Toumbis M, Kaponi M, Chrysikos S, Thanos L, Triantafillidou C. Investigation of bronchiectasis in severe uncontrolled asthma. Clin Respir J. 2018;12(3):1212–1218. doi:https://doi.org/10.1111/crj.12653.
- Coman I, Pola-Bibián B, Barranco P, Vila-Nadal G, Dominguez-Ortega J, Romero D, Villasante C, Quirce S. Bronchiectasis in severe asthma: clinical features and outcomes. Ann Allergy Asthma Immunol. 2018;120(4):409–413. doi:https://doi.org/10.1016/j.anai.2018.02.016.
- Padilla-Galo A, Olveira C, Fernández de Rota-Garcia L, Marco-Galve I, Plata AJ, Alvarez A, Rivas-Ruiz F, Carmona-Olveira A, Cebrian-Gallardo JJ, Martinez-Garcia MA, et al. Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients. Respir Res. 2018;19(1):43. doi:https://doi.org/10.1186/s12931-018-0746-7.
- Crimi C, Ferri S, Campisi R, Crimi N. The link between asthma and bronchiectasis: state of the art. Respiration. 2020;99(6):463–476. doi:https://doi.org/10.1159/000507228.
- Crimi C, Ferri S, Crimi N. Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol. 2019;19(1):46–52. doi:https://doi.org/10.1097/ACI.0000000000000492.
- Goldcopd.org. Available from: https://goldcopd.org/ [last accessed 1 July 2020].
- Ginasthma.org. Available from: https://ginasthma.org/ [last accessed 1 July 2020].
- Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629. doi:https://doi.org/10.1183/13993003.00629-2017.
- Garcha DS, Thurston SJ, Patel ARC, Mackay AJ, Goldring JJP, Donaldson GC, McHugh TD, Wedzicha JA. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax. 2012;67(12):1075–1080. doi:https://doi.org/10.1136/thoraxjnl-2012-201924.
- Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;(3):CD010115. doi:https://doi.org/10.1002/14651858.CD010115.pub2.
- Festic E, Scanlon PD. Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids? Am J Respir Crit Care Med. 2015;191(2):141–148. doi:https://doi.org/10.1164/rccm.201409-1654PP.
- Henkle E, Curtis JR, Chen L, Chan B, Aksamit TR, Daley CL, Griffith DE, Winthrop KL. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Eur Respir J. 2019;54(1):1801896. doi:https://doi.org/10.1183/13993003.01896-2018.
- Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:https://doi.org/10.1183/09031936.05.00034805.
- Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:https://doi.org/10.1016/j.jaci.2003.09.008.
- Pasteur MC, Bilton D, Hill AT, British thoracic society bronchiectasis non-CF guideline group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65(Suppl 1):i1–i58. doi:https://doi.org/10.1136/thx.2010.136119.
- Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS, et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017;49(6):1700051. doi:https://doi.org/10.1183/13993003.00051-2017.
- Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J Comput Assist Tomogr. 1982;6(3):437–444. doi:https://doi.org/10.1097/00004728-198206000-00001.
- Martínez-García M-A, de la Rosa Carrillo D, Soler-Cataluña J-J, Donat-Sanz Y, Serra PC, Lerma MA, Ballestín J, Sánchez IV, Selma Ferrer MJ, Dalfo AR, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(8):823–831. doi:https://doi.org/10.1164/rccm.201208-1518OC.
- Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991;179(3):783–788. doi:https://doi.org/10.1148/radiology.179.3.2027992.
- Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576–585. doi:https://doi.org/10.1164/rccm.201309-1575OC.
- EMBARC. Available from: https://www.bronchiectasis.eu/severity-assessment [last accessed 1 July 2020].
- Evans SA, Turner SM, Bosch BJ, Hardy CC, Woodhead MA. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J. 1996;9(8):1601–1604. doi:https://doi.org/10.1183/09031936.96.09081601.
- Davies G, Wells AU, Doffman S, Watanabe S, Wilson R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J. 2006;28(5):974–979. doi:https://doi.org/10.1183/09031936.06.00074605.
- Chawla K, Vishwanath S, Manu MK, Lazer B. Influence of pseudomonas aeruginosa on exacerbation in patients with bronchiectasis. J Glob Infect Dis. 2015;7(1):18–22. doi:https://doi.org/10.4103/0974-777X.150885.
- Murphy MB, Reen DJ, Fitzgerald MX. Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax. 1984;39(3):179–184. doi:https://doi.org/10.1136/thx.39.3.179.
- Varpela E, Laitinen LA, Keskinen H, Korhola O. Asthma, allergy and bronchial hyper-reactivity to histamine in patients with bronchiectasis. Clin Allergy. 1978;8(3):273–280. doi:https://doi.org/10.1111/j.1365-2222.1978.tb03224.x.
- Niksarlıoğlu EY, Işık R, Uysal MA, Ünal D, Çamsarı G. Prevalence of atopy and allergic rhinitis in patients with adult non-cystic fibrosis bronchiectasis. Turk J Med Sci. 2019;49(2):551–557. doi:https://doi.org/10.3906/sag-1807-229.
- Säynäjäkangas O, Keistinen T, Tuuponen T, Kivelä SL. Links between hospital diagnoses of bronchiectasis and asthma. Allergy. 1997;52(11):1120–1122. doi:https://doi.org/10.1111/j.1398-9995.1997.tb00186.x.
- Wheatley LM, Togias A. Clinical practice. Allergic rhinitis. N Engl J Med. 2015;372(5):456–463. doi:https://doi.org/10.1056/NEJMcp1412282.
- Cole PJ. Inflammation: a two-edged sword–the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6–15.
- Carpagnano GE, Scioscia G, Lacedonia D, Curradi G, Foschino Barbaro MP. Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab. JAA. 2019;12:83–90. doi:https://doi.org/10.2147/JAA.S196200.
- Rademacher J, Konwert S, Fuge J, Dettmer S, Welte T, Ringshausen FC. Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series. Eur Respir J. 2020;55(1):1901333. doi:https://doi.org/10.1183/13993003.01333-2019.
- Mauad T, Silva LFF, Santos MA, Grinberg L, Bernardi FDC, Martins MA, Saldiva PHN, Dolhnikoff M. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care Med. 2004;170(8):857–862. doi:https://doi.org/10.1164/rccm.200403-305OC.
- Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol. 1986;77(4):527–537. doi:https://doi.org/10.1016/0091-6749(86)90341-6.
- Dunican EM, Elicker BM, Gierada DS, Nagle SK, Schiebler ML, Newell JD, Raymond WW, Lachowicz-Scroggins ME, Di Maio S, Hoffman EA, et al. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Invest. 2018;128(3):997–1009. doi:https://doi.org/10.1172/JCI95693.
- Takemura M, Niimi A, Minakuchi M, Matsumoto H, Ueda T, Chin K, Mishima M. Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest. 2004;125(4):1352–1358. doi:https://doi.org/10.1378/chest.125.4.1352.
- Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Chung KF. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J. 2004;24(1):122–128. doi:https://doi.org/10.1183/09031936.04.00077803.
- Polverino E, Rosales-Mayor E, Dale GE, Dembowsky K, Torres A. The role of neutrophil elastase inhibitors in lung diseases. Chest. 2017;152(2):249–262. doi:https://doi.org/10.1016/j.chest.2017.03.056.
- Tsikrika S, Dimakou K, Papaioannou AI, Hillas G, Thanos L, Kostikas K, Loukides S, Papiris S, Koulouris N, Bakakos P, et al. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis. Cytokine. 2017;99:281–286. doi:https://doi.org/10.1016/j.cyto.2017.08.005.
- Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018;6(9):715–726. doi:https://doi.org/10.1016/S2213-2600(18)30053-5.